Laryngeal Nerve Block for Chronic Cough

Status unconfirmed · Phase 4 · Has a placebo group

Conditions studied: Laryngeal Nerve Block, Chronic Neurogenic Cough, Laryngeal Hypersensitivity

In brief

The purpose of this study is to study the potential benefit of treating chronic neurogenic cough by blocking the nerve responsible for the disease with an injection of local anesthetic/steroid mixture versus a placebo.

Key facts

Study ID

NCT05292677

Run by

Eastern Virginia Medical School

People needed

40

Starts

2021-07-21

Expected to finish

2023-06-25

Last updated by the study team

2022-03-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years and older
• Previously or Newly Diagnosed Chronic Neurogenic Cough

You may not qualify if…

• History of Laryngeal Surgery or External Beam Radiation
• Current Smokers
• Known Allergy or Sensitivity to Local Anesthetics
• Uncontrolled Pulmonary, SinoNasal, or GastroIntestinal Pathology leading to Refractory Chronic Cough

Where it is running

• Eastern Virginia Medical School Ear, Nose, and Throat Surgeons — Norfolk, Virginia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.